Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

214 results about "Retinopathy" patented technology

Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Age-related macular degeneration is technically included under the umbrella term retinopathy but is often discussed as a separate entity. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of systemic disease as seen in diabetes or hypertension. Diabetes is the most common cause of retinopathy in the U.S. as of 2008. Diabetic retinopathy is the leading cause of blindness in working-aged people. It accounts for about 5% of blindness worldwide and is designated a priority eye disease by the World Health Organization.

Polymer-based gel implant for retinal therapy and methods of making and using the same

PendingUS20250017769A1Pharmaceutical delivery mechanismEye treatmentOphthalmologyRetinal treatments
Disclosed herein are embodiments of a polymer-based gel implant and methods of making and using the same. The polymer-based gel implant comprises a polymer component and a therapeutic agent. In some embodiments, the polymer-based gel implant can be used to treat and / or prevent retinal diseases and / or retinopathies. The polymer-based gel implant exhibits physical properties that provide the ability to safely place the polymer-based gel implant in an ocular region without undesired diffusion and also to allow for controlled and timely release of the therapeutic agent to a desired region of the ocular region, such as the retina. In particular disclosed embodiments, the polymer-based gel implant can be used for safe and effective gene therapy.
Owner:UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION

Establishment method of animal model for age-related retinopathy caused by lipid metabolism disorder

The invention discloses a method for establishing an animal model for age-related retinopathy caused by lipid metabolism disorder, and the animal model is obtained by specifically knocking out Lss genes from mouse retinal pigment epithelium (RPE) cells by means of a CRISPR / Cas9 gene editing technology. The age-related retinopathy model mouse constructed by the invention shows a retinopathy phenotype with retinal lipid deposition and reduced visual function at the age of 5 months, and the retinopathy is further aggravated along with the increase of the age of the mouse and is similar to the phenotype of age-related retinopathy related to lipid metabolism disorder clinically; and an ideal and effective animal model is provided for researching age-related retinopathy.
Owner:ZHONGSHAN OPHTHALMIC CENT SUN YAT SEN UNIV

Modulation of WNT signalling in ocular disorders

The present invention provides methods of treating ocular disorders with modulators of the WNT signaling pathway. In particular the ocular disorders are retinopathies. Also provided are methods of dosing and pharmaceutical compositions.
Owner:SURROZEN OPERATING INC

Prediction method and system for retinopathy symptoms of premature infants

The invention relates to the field of image processing, in particular to a premature infant retinopathy symptom prediction method and system. The method comprises the following steps: acquiring a plurality of angle retina images and risk factor information; performing noise reduction and redundancy elimination processing; constructing a feature extraction network; carrying out feature fusion on the plurality of angle features to obtain a fused feature; extracting features of the risk factor information through a stacked auto-encoder to obtain risk factor features; performing feature splicing on the fusion feature and the risk factor feature to obtain a final feature; and obtaining a prediction result according to the final features. According to the method, a plurality of retina images shot from different angles are adopted, features obtained in the images are spliced with risk factor features, and the influence of corrected gestational age on the retinopathy of the premature infant during treatment is considered, so that the intelligent prediction effect of the retinopathy symptom of the premature infant is improved.
Owner:GUANGDONG UNIV OF TECH

Traceable mitochondrial targeting nano system as well as preparation method and application thereof

The invention provides a traceable mitochondrial targeting nano system as well as a preparation method and application thereof, and belongs to the field of medicines. The traceable mitochondrial targeting nano system constructed by the invention can continuously release resveratrol and maintain the photochemical stability of resveratrol. The nano system shows efficient cellular uptake and accurate mitochondrial targeting ability, and promotes removal of mitochondrial ROS and adjustment of mitochondrial autophagy, so that vascular leakage and angiogenesis are relieved, in-vivo microvascular hyperplasia and retina degeneration are remarkably inhibited, and the curative effect is improved. The distribution of the compound in fundus can be monitored in real time through clinical ophthalmological diagnosis equipment, and the compound has a good application prospect in preparation of drugs for preventing and / or treating diabetic retinopathy.
Owner:SICHUAN UNIV

Treatment of diabetic retinopathy with ophthalmic compositions

The present disclosure relates to a method for stabilizing the pH of an aqueous composition comprising a drug which is prone to oxidation, said method comprising the addition of an additive to prevent oxidation of the drug which is prone to oxidation. In particular, the present disclosure relates to a method for stabilizing the pH of an aqueous composition comprising a corticosteroid, said method comprising the addition of an additive to prevent oxidation of the corticosteroid. The present disclosure also relates to a composition comprising a corticosteroid and an additive to prevent oxidation of the corticosteroid.
Owner:OCULIS OPERATIONS SARL

Premature infant retinopathy detection method and device, storage medium and electronic equipment

The invention provides a premature infant retinopathy detection method and device, a storage medium and electronic equipment, and relates to the field of image processing. The method comprises the following steps: acquiring a fundus image of a target premature infant; if the eye fundus image contains the local blood-vessel-free region, determining a target boundary region between the blood-vessel region and the blood-vessel-free region in the eye fundus image; determining boundary regions on two sides of the target boundary region, and performing boundary line extraction on the boundary regions to obtain two target boundary lines; when the included angle between the two target boundary lines is greater than or equal to the target angle, determining that the detection result of the fundus image is not the retinopathy of the premature infant; and under the condition that the included angle between the two target boundary lines is smaller than the target angle, determining that the detection result of the fundus image is the retinopathy of the premature infant. According to the invention, errors of artificial subjective judgment can be reduced, and the detection efficiency is improved.
Owner:EVISION TECH (BEIJING) CO LTD

Premature infant retinopathy onset risk prediction method and system

PendingCN120072319AImage enhancementMedical data miningRetinal blood vesselsBlood flow
The invention relates to the technical field of premature infant disease prediction, in particular to a premature infant retinopathy onset risk prediction method and system, and the method comprises the following steps: S1, clinical data collection: collecting the clinical data of a premature infant; s2, retina image data acquisition: acquiring retina image data of a premature infant, and acquiring microstructure and blood flow state information of retina blood vessels; s3, data preprocessing: preprocessing the acquired retina image data and clinical data; s4, correlation analysis of the retina image and clinical data: revealing potential correlation between the retina image and the health condition of the premature infant, and predicting the occurrence probability of retinopathy; s5, risk assessment and intervention suggestion: dynamically assessing the retinopathy risk of the premature infant, and providing personalized intervention suggestions; according to the method, high-value features in multi-source data are effectively captured, and the prediction accuracy of retinopathy is improved.
Owner:NANCHANG FIRST HOSPITAL

Polymer-based implant for retinal therapy and methods of making and using the same

Disclosed herein are embodiments of a polymer-based implant and methods of making and using the same. The polymer-based implant comprises a polymer component and a therapeutic agent. In some embodiments, the polymer-based implant can be used to treat and / or prevent retinal diseases and / or retinopathies. The polymer-based implant exhibits physical properties that provide the ability to safely place the polymer-based implant in an ocular region without undesired diffusion and also to allow for controlled and timely release of the therapeutic agent to a desired region of the ocular region, such as the retina. In particular disclosed embodiments, the polymer-based implant can be used for safe and effective gene therapy.
Owner:UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION

Detection of genetic variants of the beta-adrenergic receptor pathway for detecting and treating retinopathy of prematurity

PendingUS20250066855A1HydrolasesMicrobiological testing/measurementDiseaseHereditary Mutation
Described herein are methods for the identification and detection of genetic factors in the molecular pathways associated with vascular retinopathies or retinal diseases, for example mild, moderate or severe retinopathy of prematurity (ROP). Included herewith are methods of detecting genetic mutations associated with severe retinopathies, including factors in ADRβ2 pathways, which include RAPGEF3, ADCY7, ADCY9, PRKARIA, and ADCY4 variants. Further, this disclosure provides for methods of treating a subject having a detected genetic factor indicative of ROP.
Owner:GOOD WILLIAM VANCE +3

Method for simulating diabetic retinopathy process

The invention discloses a diabetic retinopathy process simulation method. The method comprises the steps that a two-dimensional discrete coordinate system is constructed, and a blood vessel index function describing unit grid attributes of unit grids is defined; updating the blood glucose concentration, the oxygen concentration, the fibronectin concentration and the growth factor concentration of each unit grid every preset time t; predicting the movement direction of each blood vessel tip in the t time period according to the fibronectin concentration and the growth factor concentration; calculating a first predicted extension distance and a second predicted extension distance according to the motion direction in the current t time period and the motion direction in the last t time period; and updating the unit grid attribute of each unit grid in the two-dimensional discrete coordinate system according to the movement direction in the t time period, the blood vessel existence time of the blood vessel tip and the movement extension distance calculated by the blood vessel tip. According to the method, the oxygen concentration and the blood glucose concentration are incorporated into the model for simulating vascular extension, and accurate simulation prediction of diabetic retinopathy is achieved.
Owner:BEIJING GENERAL AEROSPACE HOSPITAL

Application of triptolide in preparation of medicine for treating diabetic vascular obstruction complications

The invention belongs to the field of new application of medicines, and particularly relates to application of triptolide in preparation of medicines for treating diabetic vascular obstruction complications. Diabetes vascular obstruction is a common serious complication of diabetes and can cause various tissue injuries such as cardiovascular diseases, nephropathy and retinopathy. Experiments prove that the triptolide can remarkably improve the problems of blood vessel blockage, blood flow slowing, abnormal neovascularization and the like caused in a high-glucose environment, and meanwhile, the expression of blood glucose related indexes (such as Glucose and HbA1c) and inflammatory factors (such as TNF-alpha and IL-1beta) is reduced. In addition, triptolide can also protect pancreas from high glucose damage and improve functions of pancreatic beta cells. According to the invention, the clinical application range of the triptolide is expanded, and a new candidate substance is provided for drug treatment of diabetic vascular complications.
Owner:FIRST AFFILIATED HOSPITAL OF GANNAN MEDICAL UNIV

Bidirectional prediction method, control device, storage medium and system

The embodiment of the invention provides a bidirectional prediction method based on an eye fundus image and a physical examination index, a control device, a storage medium and a system, and belongs to the technical field of medical treatment. The bidirectional prediction method comprises the following steps: for a plurality of target detectors, obtaining fundus images of each target detector and data of a plurality of physical examination indexes; based on a bidirectional prediction feedback mechanism, determining correlation between the features of the fundus image and the multiple physical examination indexes, and predicting retinopathy through the multiple physical examination indexes to obtain a bidirectional prediction result; and detecting a person to be detected based on the bidirectional prediction result. According to the embodiment of the invention, intelligent whole body disease prediction is carried out based on a bidirectional prediction feedback mechanism, bias caused by data and other problems can be avoided, and the reliability and accuracy of intelligent disease prediction based on the fundus image and the whole body examination index are improved.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL +1

Weakly supervised learning diabetic retinopathy grading and lesion identification method and system

The present invention relates to a weakly supervised learning diabetic retinopathy grading and lesion identification method and system, the method comprising: S1: inputting a diabetic retinopathy fundus color image into a CNN network to obtain a feature map F; inputting F into a lesion point capture module based on weakly supervised object positioning, selecting to enter a branch module, calculating a score map, multiplying the score map with the feature map F to obtain a new feature map F'; S2: using an optimal network structure search module based on reinforcement learning to calculate the insertion position, selection probability, feature discarding threshold and retention threshold of the weakly supervised lesion point capture module in the CNN network, and finally outputting the feature map F. NA S3: Lesion attribute prediction and disease classification are obtained through attribute mining and lesion identification modules. S4: Based on the results of S3, the final lesion identification result is obtained through multiple iterative erasure calculations. The method provided by the present invention can improve the effectiveness of lesion capture and use lesion mining methods to determine lesion type, providing a basis for disease classification.
Owner:BEIHANG UNIV

Compositions for treating diabetic retinopathy comprising peptides

The present invention relates to a composition for preventing or treating diabetic retinopathy, comprising a peptide having an excellent effect of inhibiting the generation of neovascularization in the retina, the loss of perivascular cells, and the expansion of blood vessels. The present invention can be effectively used in the prevention or treatment of retinopathy by inhibiting increase in vascular permeability, inflammation, and the occurrence of neovascularization.
Owner:IBIO KOREA

Nitrogen-containing tricyclic compound and pharmaceutical use thereof

The present invention provides a compound having a PDHK inhibitory activity and useful for the treatment or prophylaxis of diabetes (type 1 diabetes, type 2 diabetes etc.), insulin resistance syndrome, metabolic syndrome, hyperglycemia, hyperlactacidemia, diabetic complications (diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, cataract etc.), cardiac failure (acute cardiac failure, chronic cardiac failure), cardiomyopathy, myocardial ischemia, myocardial infarction, angina pectoris, dyslipidemia, atherosclerosis, peripheral arterial disease, intermittent claudication, chronic obstructive pulmonary diseases, brain ischemia, cerebral apoplexy, mitochondrial disease, mitochondrial encephalomyopathy, cancer, pulmonary hypertension, Alzheimer disease, vascular dementia, glaucoma, diabetic retinopathy, retinopathy of prematurity, retinal vein occlusion, ischemic optic neuropathy or chronic kidney disease. The present invention relates to a compound of the formula [I], the formula [II] or the formula [III], or a pharmaceutically acceptable salt thereof:wherein each symbol is as defined in the DESCRIPTION.
Owner:SHIONOGI & CO LTD

Differential analysis system and method for traditional Chinese medicine diabetic retinopathy based on artificial intelligence

The invention discloses a traditional Chinese medicine diabetic retinopathy difference analysis system and method based on artificial intelligence, and relates to the technical field of artificial intelligence, and the system comprises a real-time adjustment end, a difference analysis end and a formula generation end; the real-time adjusting end is used for automatically generating retina image texture information of the diabetic patient through an image converter by detecting the retina texture of the diabetic patient in real time; the difference analysis end is used for receiving a retinal texture comparison result of a diabetic patient in real time; the formula generation end is used for receiving the retinopathy difference data in real time and taking standard traditional Chinese medicine formulas set by different lesions as the basis according to the retinopathy difference data. According to the traditional Chinese medicine diabetic retinopathy difference analysis system and method based on artificial intelligence, the retina comparison image is zoomed or expanded in real time according to the sizes of retinas of different patients, the accuracy of diabetic retina difference analysis is improved, and the accuracy of diabetic retina difference analysis is improved.
Owner:THE THIRD MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY GENERAL HOSPITAL

Imidazodiazepine and its method of use

We provide TRPC5 inhibitors for use in treating or reducing the risk of developing kidney disease, diabetic retinopathy, anxiety disorders, depression, or cancer. [Solution] Compounds according to formula (I) or (II), and pharmaceutical compositions containing them are disclosed. A therapeutic method using a compound of formula (I) or (II) to treat, for example, kidney disease is also disclosed. JPEG2026086459000081.jpg3992
Owner:GOLDFINCH BIO INC

Artificial intelligence-based retinopathy recognition method, system and device and medium

The invention relates to the technical field of image processing, in particular to a retinopathy recognition method, system and device based on artificial intelligence and a medium, and the method comprises the steps: taking the eye of a detected pregnant woman as a target object, setting a preset position, scanning in the depth direction, obtaining point fault information, carrying out three-dimensional reconstruction, and generating a second image. Generating a third image, performing correction processing, presetting a straight line in the corrected image, obtaining pixel values corresponding to the positions where the first pixel and the second pixel are located, and obtaining the thickness data of each layer; taking the thickness data as a pixel value; setting the value of each layer of pixel to be equal to the thickness data of the layer; generating a fourth image; and establishing an image database, adding a disease marker to the reference image, training the image estimation model by using the reference image added with the disease marker, and outputting a disease corresponding to the fourth image. The method improves the prediction efficiency and accuracy of the eye fundus image.
Owner:PEOPLES HOSPITAL OF HENAN PROV

Compositions for use in treating autosomal dominant BEST1-related retinopathies

The present invention refers to a sgRNA molecule comprising a targeting domain for specifically targeting a SNP in the BEST1 coding region of a pathologic allele, wherein said targeting domain consists of a sequence selected from the group consisting of SEQ ID NO: 3-8, 41-44, 14-20, 50-52 and 54-55, or a sgRNA molecule combination of specifically defined first and second sgRNA molecules, wherein the first and the second sgRNA molecule each comprise a targeting domain for specifically targeting a SNP in the BEST1 gene coding or non-coding region of a pathologic allele. The present invention also refers to a nucleic acid comprising a sequence that encodes the sgRNA molecule or sgRNA molecule combination and to nucleic acid combinations. The present invention further relates to a recombinant adenovirus-associated virus (AAV) comprising the nucleic acids according to the present invention or recombinant AAV combinations. The sgRNA molecule, the nucleic acid, the recombinant AAV and combinations are useful tools for editing of the target domain in the bestrophin-1 (BEST1) gene to restore BEST1 channel function by e.g. CRISPR / Cas9)-based gene editing. The present invention further relates to the sgRNA molecule, the sgRNA molecule combination, the nucleic acid, the nucleic acid combination, the recombinant AAV and the recombinant AAV combination for use in a method for treatment of the human or animal body by surgery or therapy and for use in method of treating or preventing BEST1-related retinopathies, in particular autosomal dominant BEST1-related retinopathies.
Owner:UNIVERSITY OF REGENSBURG

Application of AMG-487 in preparation of medicine for treating retinopathy of premature infant

The invention belongs to the technical field of pharmacy, and particularly relates to application of AMG-487 in preparation of a medicine for treating premature infant retinopathy, and the medicine is used for treating the premature infant retinopathy by blocking combination of CXCL10 or / and CXCR3 in the ROP high oxygen period. Through research, the inventor finds that expression of CXCL10 in a blood sample of a patient with ROP is remarkably increased, TFR, HIF-1alpha, STAT3 and PTGS2 in a ferroptosis pathway have remarkable correlation with the CXCL10, AMG-487 can inhibit combination of CXCL10 / CXCR3 so as to reduce expression of TFR, HIF-1alpha, STAT3 and PTGS2 in the ferroptosis pathway, the effect of preventing and / or treating the retinopathy (ROP) of premature infants is achieved, ROP can be effectively treated, and the application prospect is wide. The compound is expected to become a novel medicine for treating ROP diseases and has important clinical application value.
Owner:TIANJIN EYE HOSPITAL

A method for processing diabetic retinopathy image data

The present invention relates to a method for processing diabetic retinopathy image data, and the method includes: data preprocessing: obtaining a high-definition fundus image X, obtaining a preprocessed high-definition fundus image #imgabs0# through noise reduction and detail enhancement, and then obtaining a preprocessed high-definition fundus image #imgabs1# with a smaller resolution through scaling and data enhancement; feature extraction: inputting the preprocessed high-definition fundus image #imgabs2# with a smaller resolution into a convolutional neural network A to obtain a feature map F; respectively adopting an overall processing branch processing method and a region of interest processing branch processing method to obtain a global processing result y whole and a region of interest processing result y attention ; averaging the scores of the global processing result y whole and the region of interest processing result y attention to obtain a final processing result y pred . Compared with the prior art, the present invention has the advantages of high accuracy, high robustness, and saving computing resources.
Owner:TONGJI UNIV

Premature infant retinopathy diagnosis system based on equivariant convolutional network

The invention relates to the technical field of medical image processing, and discloses a premature infant retinopathy diagnosis system based on an isotropic convolutional network, which comprises an image acquisition module, a segmentation module, a partition module, a staging module and a result generation module. The segmentation module is used for processing the retina image by adopting an equivariant convolutional network, and accurately segmenting an optic disc and a lesion area; the partitioning module divides a retina region according to an optic disc segmentation result; the staging module integrates the lesion segmentation result and the zoning result to output lesion staging; and the result generation module integrates all information to generate a comprehensive diagnosis report. According to the premature infant retinopathy diagnosis method and system, the image segmentation precision is improved through the equivariant convolutional network, and the automatic and high-accuracy comprehensive diagnosis of the premature infant retinopathy is realized by utilizing the cooperative work of the modules, so that the clinical diagnosis and treatment decision is effectively assisted.
Owner:WOMEN & CHILDRENS MEDICAL CENTER AFFILIATED WITH GUANGZHOU MEDICAL UNIVERSITY

ALDOSE REDUCTION INHIBITORS AND THEIR USES

UndeterminedCY1125692T1Diabetic retinopathyRenal disorder
The present invention relates to novel compounds and pharmaceutical compositions thereof, and to methods for promoting healthy skin aging, treating skin disorders, treating cardiovascular disorders, treating renal disorders, treating angiogenesis disorders, such as cancer, treating tissue damage, such as non-cardiac tissue damage, treating progressive myocardial infarction, and treating various other disorders, such as complications resulting from diabetes with the compounds and compositions of the invention. Other disorders may include, but are not limited to, atherosclerosis, coronary artery disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, skin infections, peripheral vascular disease, stroke, and the like.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK